Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 11 Prostatic Neoplasms 9 Uterine Neoplasms 2 Hyperthermia 2 Endometrial Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Rhabdomyosarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Locally Advanced Cervical Adenocarcinoma 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Directly Observed Therapy 1 Cervical Adenocarcinoma 1 Carcinoma, Renal Cell 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 23 venetoclax 17 Dexamethasone 16 pembrolizumab 15 fludarabine 15 Cytarabine 13 pomalidomide 8 Rituximab 8 Gemcitabine 8 Carboplatin 8 Azacitidine 8 glofitamab 7 fludarabine phosphate 7 Lenalidomide 7 selinexor 6 Paclitaxel 6 Injections 6 Immunotherapy, Adoptive 6 Granulocyte Colony-Stimulating Factor 6 Cisplatin 6 daratumumab 5 Temozolomide 5 Bevacizumab 5 zanubrutinib 4 ruxolitinib 4 Surgical Procedures, Operative 4 Oxaliplatin 4 Nivolumab 4 Drug Therapy 4 Decitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Brachytherapy × Clear all

NCT05715502 2025-04-30

FocaSaBra

The Greater Poland Cancer Centre

Phase NA Recruiting

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡